Literature DB >> 12507897

Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains.

Stefanie Gaupp1, David Pitt, William A Kuziel, Barbara Cannella, Cedric S Raine.   

Abstract

Chemokines are low molecular weight cytokines which act as chemoattractants for infiltrating cells bearing appropriate receptors (CCR) to sites of inflammation. It has been proposed that CCR2 on monocytes is responsible for their recruitment into the central nervous system (CNS) in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis, and two previous reports have described resistance of CCR2(-/-) mice to EAE. The present study examined three different mouse strains with CCR2 deletions for susceptibility to EAE. Animals were studied up to 4 months post-sensitization and were examined by neuropathology, RNase protection assay, in situ hybridization, and in vitro assays. All three strains were found to be susceptible to EAE: C57BL/6 x J129 and Balb c strains, 100%; and C57BL/6, 67%. Unusual in CNS lesions of CCR2(-/-) mice was an overabundance of neutrophils versus monocytes in wild-type animals. An attempt of the immune system to develop compensatory mechanisms for the lack of CCR2 was evidenced by a corresponding increase in mRNA for other chemokines and CCR. Inasmuch as neutrophils replaced monocytes and led to demyelination, our findings support the concept that promiscuity of chemokines and CCR was able to surmount the deletion of CCR2, still resulting in full expression of this autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507897      PMCID: PMC1851120          DOI: 10.1016/S0002-9440(10)63805-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

Review 1.  CC chemokines in allergic inflammation.

Authors:  M Baggiolini; C A Dahinden
Journal:  Immunol Today       Date:  1994-03

2.  Blood, sweat, and chemotactic cytokines.

Authors:  P M Murphy
Journal:  J Leukoc Biol       Date:  1995-03       Impact factor: 4.962

3.  Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis.

Authors:  L G Epstein; J W Prineas; C S Raine
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

Review 4.  Chemotactic and inflammatory cytokines--CXC and CC proteins.

Authors:  M Baggiolini
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

Review 5.  Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.

Authors:  C S Raine
Journal:  Lab Invest       Date:  1984-06       Impact factor: 5.662

6.  Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis.

Authors:  A H Cross; B Cannella; C F Brosnan; C S Raine
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

7.  Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta.

Authors:  D D Taub; K Conlon; A R Lloyd; J J Oppenheim; D J Kelvin
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

8.  Immunogold localization and analysis of IgG during immune-mediated demyelination.

Authors:  G R Moore; C S Raine
Journal:  Lab Invest       Date:  1988-11       Impact factor: 5.662

9.  Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta.

Authors:  B Sherry; P Tekamp-Olson; C Gallegos; D Bauer; G Davatelis; S D Wolpe; F Masiarz; D Coit; A Cerami
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor.

Authors:  J L Gao; D B Kuhns; H L Tiffany; D McDermott; X Li; U Francke; P M Murphy
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  46 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

2.  Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Authors:  Daniel Larocque; Nicholas S R Sanderson; Josée Bergeron; James F Curtin; Joe Girton; Mia Wibowo; Niyati Bondale; Kurt M Kroeger; Jieping Yang; Liliana M Lacayo; Kevin C Reyes; Catherine Farrokhi; Robert N Pechnick; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

3.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

4.  T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.

Authors:  Sara Abromson-Leeman; Rod Bronson; Yi Luo; Michael Berman; Rebecca Leeman; Joshua Leeman; Martin Dorf
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease.

Authors:  Emily R Pierson; Joan M Goverman
Journal:  JCI Insight       Date:  2017-04-06

6.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

7.  Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1.

Authors:  Kakuri M Omari; Sarah E Lutz; Laura Santambrogio; Sergio A Lira; Cedric S Raine
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

8.  C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

Authors:  Andrea Reboldi; Caroline Coisne; Dirk Baumjohann; Federica Benvenuto; Denise Bottinelli; Sergio Lira; Antonio Uccelli; Antonio Lanzavecchia; Britta Engelhardt; Federica Sallusto
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

9.  T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis.

Authors:  Magdalena J Polanczyk; Richard E Jones; Sandhya Subramanian; Michael Afentoulis; Cathleen Rich; Melissa Zakroczymski; Paul Cooke; Arthur A Vandenbark; Halina Offner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury.

Authors:  Teresa A Evans; Deborah S Barkauskas; Jay T Myers; Elisabeth G Hare; Jing Qiang You; Richard M Ransohoff; Alex Y Huang; Jerry Silver
Journal:  Exp Neurol       Date:  2014-01-24       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.